North America dominates the Pharmaceutical Contract Manufacturing Market | Key players are HAUPT Pharma AG, Abbott Laboratories, NextPharma, Catalent Pharma Solutions

The global market for pharmaceutical contract manufacturing represents one of the fastest growing markets and it is expected to proffer enormous opportunities in the near future. Contract manufacturing contributes significantly to the overall outsourcing market, owing to its popularity and widespread adoption by pharmaceutical companies.

Get the Sample Report: https://www.alliedmarketresearch.com/request-toc-and-sample/461?utm_source=openpr&utm_medium=Niranjan

Cost containment issues resulted from global economic constraints, have exerted extensive pressure on pharmaceutical manufacturers to reduce the cost of products. Hence, to make the way out of this situation, pharma companies are looking to reduce the manufacturing cost. Contract manufacturing, as a strategic option, offers certain benefits such as cost reduction, improved product quality, product portfolio and reduction in time to market. Contract manufacturing also supports the pharmaceutical companies to focus on R&D and marketing activities by minimizing the time and efforts invested in manufacturing activity.

Hence, contract manufacturing is the largely accepted trend in recent years. HAUPT Pharma AG, Abbott Laboratories, NextPharma, Catalent Pharma Solutions, Althea Technologies, Jubilant Life Sciences Limited, Royal DSM N.V, and Nipro Corp. are some of the big players of this market. Patent expiration of major therapeutic brands, growing demand for generic drugs and the adoption of novel manufacturing technologies are expected to boost the growth of this market.

The global market for pharmaceutical contract manufacturing is segmented based on the type of contract manufacturing and geography. Based on the type of contract manufacturing, the market is segmented as, Active Pharmaceutical Ingredients (API) / Bulk drug, Final Dosage Form (FDF), advanced drug delivery products, OTC medicines, and Nutritional products and Packaging contract manufacturing. The final dosage form contract manufacturing (FDF) is expected to grow with substantial CAGR due to the growing demand for generic products and rising R&D investments.

Purchase the Report @Discount: https://www.alliedmarketresearch.com/checkout/666392?utm_source=openpr&utm_medium=Niranjan

Geographically, the global market for pharmaceutical contract manufacturing is segmented into North America, Europe, Asia-Pacific, and LAMEA. North America dominates the global contract manufacturing market, whereas, Asia-Pacific is the fastest growing market due to the adoption of advanced technologies, favorable regulatory framework, reduced labor cost and availability of a skilled workforce.

KEY BENEFITS

This report offers the following benefits in particular:

In-depth coverage of drivers, restraints, and opportunities within the global market for pharmaceutical contract manufacturing would help professionals to better understand market behavior. Porter’s Five Forces analysis examines the competitive structure of the global market for pharmaceutical contract manufacturing and would assist market strategists in their respective decision-making process. Pin-point analysis of geographic segments helps to identify opportunities for growth within the global market for pharmaceutical contract manufacturing. Deep insights on key developments and regulatory framework of the global market for pharmaceutical contract manufacturing would be informative for professionals in the corporate sector.

KEY MARKET SEGMENTS

The global market for pharmaceutical contract manufacturing is segmented into two major categories such as type and geography.

MARKET BY DRUG TYPE
- Active Pharmaceutical Ingredients (API) / Bulk drug
- Final Dosage Form (FDF)
- Solid dosage form
- Semi-solid dosage form
- Liquid dosage form
- Advanced drug delivery products
- OTC medicines and Nutritional products
- Packaging

MARKET BY GEOGRAPHY
- North America
- Europe
- Asia-Pacific
- LAMEA

About Us:-

Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.